Vitrolife AB (FRA:VTFN) ROE % Adjusted to Book Value : 1.78% (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB ROE % Adjusted to Book Value?

Vitrolife AB's ROE % for the quarter that ended in Mar. 2024 was 3.52%. Vitrolife AB's PB Ratio for the quarter that ended in Mar. 2024 was 1.98. Vitrolife AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 1.78%.

Vitrolife AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Vitrolife AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB ROE % Adjusted to Book Value Chart

Vitrolife AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

1.89

1.29

0.82

1.58

-12.39

Vitrolife AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															1.40	1.53	2.42	-54.78	1.78

Competitive Comparison of Vitrolife AB's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Vitrolife AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vitrolife AB's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's ROE % Adjusted to Book Value falls into.

Vitrolife AB ROE % Adjusted to Book Value Calculation

Vitrolife AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-25.89%	/	2.09
	=	-12.39%

Vitrolife AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	3.52%	/	1.98
	=	1.78%

Vitrolife AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Vitrolife AB (FRA:VTFN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (FRA:VTFN) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

VITR:Sweden 0YAY:UK

Address

Box 9080, Gothenburg, SWE, 400 92

Website

https://www.vitrolife.com

Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB (FRA:VTFN) Headlines

No Headlines